Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Lin Xiang Gu
Age : 60
Public asset : 369,904,259 USD
Country of residence : Unknown
Linked companies : Zhejiang grandwall electric science&technology co.,ltd.

Summary 
Lin Xiang Gu is General Manager & Executive Director of Zhejiang Greatwall Electronic Science & Technology Group Co., He is also on the board of Zhejiang Grandwall Electric Science & Technology Co., Ltd. (former Chairman & General Manager).




Current positions of Lin Xiang Gu 
Holdings of Lin Xiang Gu 
Lin Xiang Gu : Personal Network 
Most Read News 
01/13Investor Peltz, corporate doctor, pushes Disney to take bitter pill
RE
01/25Musk says China rivals 'work hardest, smartest'
RE
01/13Musk bets big on beating shareholders at 'funding secured' trial
RE
01/19Ark's Wood remains bullish on Tesla, says oil stock rally 'defying logic'
RE
01/26LVMH's Arnault brushes off succession question
RE
01/19JPMorgan CEO Dimon sees interest rates going beyond 5% - CNBC
RE
01/23Musk to return to stand in fraud trial over 2018 Tesla tweet
RE
01/19Sacked GM workers in India sue company, CEO Barra for unpaid compensation
RE
01/20Musk expected to take stand as trial resumes over Tesla tweet
RE
01/26Wells Fargo CEO Scharf's 2022 pay unchanged at $24.5 million
RE
More news


© 2023 People and Ownership :   
Lin Xiang Gu : Connections 


Latest news about Lin Xiang Gu 
2022TSEC Corporation Announces Changes to Remuneration Committee
CI
2022TSEC Corporation Announces New Sustainable Committee
CI
2018Zhejiang Starry Pharmaceutical Co., Ltd. completed the acquisition of 94.67% stake in Zhejiang Hisyn Pharmaceutical Co., Ltd. from HK South West Group Limited, Ningbo Paradise Silicon Valley Asset Management Group Co., Ltd. and Tibet Silicon Valley Paradise Imperial Investment Management Co., Ltd.
CI
2018Zhejiang Starry Pharmaceutical Co., Ltd. agreed to acquire 94.67% stake in Zhejiang Hisyn Pharmaceutical Co., Ltd. from HK South West Group Limited, Ningbo Paradise Silicon Valley Asset Management Group Co., Ltd. and Tibet Silicon Valley Paradise Imperial Investment Management Co., Ltd. for approximately CNY 800 million.
CI
More news